WO2024241248 - COMPOUNDS TARGETING KRAS G12D MUTATIONS AND THEIR USES

National phase entry is expected:
Publication Number WO/2024/241248
Publication Date 28.11.2024
International Application No. PCT/IB2024/054989
International Filing Date 22.05.2024
Title **
[English] COMPOUNDS TARGETING KRAS G12D MUTATIONS AND THEIR USES
[French] COMPOSÉS CIBLANT DES MUTATIONS DE KRAS G12D ET LEURS UTILISATIONS
Applicants **
INNOPHARMASCREEN INC. 28 FL, V689, 165, Convensia-daero Yeonsu-gu Incheon 21988, KR
Inventors
KANG, Incheol 602-1204, 96, Convensia-daero 42 beon-gil, Yeonsu-gu Incheon 22001, KR
SEO, Seung O 2-402, 9, Songdomirae-ro, Yeonsu-gu Incheon 21988, KR
Priority Data
10-2023-0065774   22.05.2023   KR
front page image
Application details
Total Number of Claims/PCT *
Number of Independent Claims *
Number of Priorities *
Number of Multi-Dependent Claims *
Number of Drawings *
Pages for Publication *
Number of Pages with Drawings *
Pages of Specification *
*
*
International Searching Authority
*
Applicant's Legal Status
*
*
*
*
*
Entry into National Phase under
*
Translation

Recalculate

* The data is based on automatic recognition. Please verify and amend if necessary.

** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.

Quotation for National Phase entry

Country StagesTotal
China Filing1313
EPO Filing, Examination7359
Japan Filing598
South Korea Filing576
USA Filing, Examination5035
+ Add country
MasterCard Visa

Total: 14881

The term for entry into the National Phase has expired. This quotation is for informational purposes only

QUOTE TO EMAIL ONLINE QUOTE
Abstract[English] The present disclosure relates to compounds targeting KRAS G12D and G12V mutations and uses thereof.[French] La présente invention concerne des composés ciblant des mutations de KRAS G12D et G12V et leurs utilisations.
An error has occurred. This application may no longer respond until reloaded. Reload 🗙